New Zealand Health Terminology Service (NZHTS) Implementation Guide
0.1.0 - ci-build
New Zealand Health Terminology Service (NZHTS) Implementation Guide
0.1.0 - ci-build
New Zealand Health Terminology Service (NZHTS) Implementation Guide, published by Health New Zealand | Te Whatu Ora. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/daniel-thomson/nzhts/ and changes regularly. See the Directory of published versions
| Official URL: https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-gep-net-primary-histology | Version: 0.1.0 | |||
| Active as of 2024-11-11 | Computable Name: canshare-who-gep-net-primary-histology | |||
| Other Identifiers: http://canshare.co.nz/fhir/NamingSystem/valuesets#canshare-who-gep-net-primary-histology | ||||
Histologies used for endocrine and Neuroendocrine cancer types (WHO Classification of Tumours, Endocrine and Neuroendocrine Tumours, latest edition) 7. Pancreatic neuroendocrine neoplasms, neuroendocrine tumours 8. Neuroendocrine neoplasms in non-endocrine organs neuroendocrine tumours or an 'Other' value.
References
This value set is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)
Generated Narrative: ValueSet canshare-who-gep-net-primary-histology
version: 1; Last updated: 2024-11-05 17:09:54+1300; Language: en-x-sctlang-23162100-0210105
http://snomed.info/sct where constraint = 361591000210108 |Pancreatic neuroendocrine tumour, nonfunctioning| OR 20955008 |Insulinoma, malignant | OR 66515009 |Glucagonoma| OR 128643000 |Somatostatinoma| OR 19756007 |Gastrinoma| OR 31131002 |VIPoma| OR 302431000210102 |Serotonin-producing tumour| OR 302421000210104 |ACTH-producing tumour| OR 381751000210108 |GH-producing tumour| OR 381761000210106 |Gonadotropin-producing tumour| OR 1286768001 |Neuroendocrine tumour| OR 1286769009 |Neuroendocrine tumour grade 1| OR 1286770005 |Neuroendocrine tumour grade 2| OR 1286772002 |Neuroendocrine tumour grade 3| OR 74964007 |Other|
Generated Narrative: ValueSet canshare-who-gep-net-primary-histology
version: 1; Last updated: 2024-11-05 17:09:54+1300; Language: en-x-sctlang-23162100-0210105
Expansion based on SNOMED CT 21000210109 edition 01-Oct 2024
This value set contains 15 concepts
| Code | System | Display - English (English, en) |
| 19756007 | http://snomed.info/sct | Gastrinoma, malignant |
| 66515009 | http://snomed.info/sct | Glucagonoma, malignant |
| 381761000210106 | http://snomed.info/sct | Gonadotropin-producing neuroendocrine tumour |
| 381751000210108 | http://snomed.info/sct | Growth hormone producing neuroendocrine tumour |
| 20955008 | http://snomed.info/sct | Insulinoma, malignant |
| 302421000210104 | http://snomed.info/sct | Malignant adrenocorticotropic hormone secreting tumour |
| 302431000210102 | http://snomed.info/sct | Malignant serotonin secreting tumour |
| 74964007 | http://snomed.info/sct | Other |
| 361591000210108 | http://snomed.info/sct | Pancreatic neuroendocrine tumour, nonfunctioning |
| 128643000 | http://snomed.info/sct | Somatostatinoma, malignant |
| 31131002 | http://snomed.info/sct | Vipoma, malignant |
| 1286768001 | http://snomed.info/sct | Well-differentiated neuroendocrine tumour |
| 1286769009 | http://snomed.info/sct | Well-differentiated neuroendocrine tumour grade 1 |
| 1286770005 | http://snomed.info/sct | Well-differentiated neuroendocrine tumour grade 2 |
| 1286772002 | http://snomed.info/sct | Well-differentiated neuroendocrine tumour grade 3 |
Explanation of the columns that may appear on this page:
| Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
| System | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
| Code | The code (used as the code in the resource instance) |
| Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
| Definition | An explanation of the meaning of the concept |
| Comments | Additional notes about how to use the code |